Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act-Reference-Cited by-同舟云学术

Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act

Published:2018-01 Issue: Volume:192 Page:8-12
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Avant Debbie,Wharton Gerold T.,Murphy Dianne

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference14 articles.

1. Pragmatic assessment of medicines available for young children and pregnant or breast-feeding women. Basic and therapeutic aspects of perinatal pharmacology;Wilson,1975

2. An update on the therapeutic orphan;Wilson;Pediatrics,1999

3. Food and Drug Administration, US Department of Health and Human Services. New drug product exclusivity. 21 CFR §314.108(a).

4. Orphan Drug Act of 1983,1983

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress;Cold Spring Harbor Perspectives in Medicine;2024-03-11

2. State of the art in pediatric nanomedicines;Drug Delivery and Translational Research;2024-02-07

3. Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis;Annals of the Rheumatic Diseases;2022-12-05

4. Potential Future Drug Development Lag in Japan Based on an Analysis of Multiregional Clinical Trials in the US, Europe, and East Asia;Therapeutic Innovation & Regulatory Science;2022-02-18

5. Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial): A Randomized Controlled Trial: Background, Aims and Study Protocol;Frontiers in Pain Research;2021-12-07